FDA Investigator Taichun Qin, PhD

Taichun Qin, PhD has conducted inspections on 84 sites in 9 countries as of 29 Apr 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
84
Last Inspection Date:
29 Apr 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
India, China, United States of America, Spain, United Kingdom of Great Britain and Northern Ireland, France, Malta, Canada, Mexico
FDA Investigators that have inspected at least one site in common with Taichun Qin, PhD:
Ademola O Daramola, Alan L Truong, Alan P Kurtzberg, Albert C Cheng, Alexandra B Pitkin, Alexandria L Capuano, Althea A Williams, Amalia C Himaya, Amanda L Fyles, Amir Alavi, Anderson, Andrew K Haack, PhD, Andrew Le, Angela E Glenn, Anita Narula, PhD, Anna L Marroquin, Arie C Menachem, Arindam Dasgupta, PhD, Arsen Karapetyan, Ashar P Parikh, Ashley J Allen Gaines, Ashley N Queen, PhD, Azza Talaat, Babajide Michael Osunsanmi, Barbara J Rincon, Barry Cherney, PhD, Bichsa T Tran, Binh T Nguyen, Bo Chi, PhD, Brian P Putz, Brien C Fox, Bryan A Galvez, Bryan L Mcguckin, Bryce A Hammer, Bryce A May, Carla J Lundi, Carolina D Vasquez, Carrie A Hughes, Caryn M Everly, Caryn M Mcnab, Cassandra L Abellard, Cathleen A Carr Sharpe, CDR Rochelle B Young, RPh, MSA, Cecilia H Kieu, Chaoying C Ma, Charisse K Green, Chelsea N Sealey, Cheron M Portee, Christina C Santos, Christina V Santos, Christopher M Jenner, Christopher R Czajka, Christopher T Middendorf, Claire M Minden, Claudia Mperez Kasmarski, Comyar Shoghi, Constance Y Fears, Crystal Monroy, Daniel J Roberts, Daniel R Solis, Daniel W Cline, Darren S Brown, Daryl A Dewoskin, David G Whitman, David Serrano, David Y Hernandez, Davinna Ligons, PhD, Deborah A Greco, Debra J Fracassa, Demitria J Xiradakis, Dennis Cantellops Paite, Diana M Rand, Diane Cvan Leeuwen, Dipesh K Shah, Djamila Harouaka, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Donna Ltartaglino Besone, Doretha M Tonkins, Doretha M Wilson, Douglas C Kovacs, Dr. Gang Wang, PhD, Dr. Robert C Horan, MD, Dr. S Nar Ali, PhD, Edward D Mcdonald, Emest F Bizjak, Erik M Slama, Erika V Butler, Estefania Fernandez, Esther B Gamallo Herrera, Esther C Broner, PhD, Eugene Y Chang, Evelyn Wong, Farhana Khan, Felix Maldonado, Frances Namuswe, PhD, Francisco, Freddy Ortiz Colon, Frederick F Razzaghi, Gabriel M Guevarra, Gam S Zamil, Garciam, Gavin T Cua, Gene D Arcy, Gene R Gunn, Grace Deneke, Greg K Keshishyan, Gunneet Kaur, Gwyn G Dickinson, Haley H Seymour, Haroon Vohra (NMI), Hasan A Irier, PhD, Heidy C Perales, Helen B Ricalde, Henry E Carrillo, Iris C Macinnes, James B Arnett, James R Fleckenstein, James S Cartwright, Jane L Chang, Jane S Wernberg, Jay T Wong, Jee Chung, PhD, Jeff M Uriarte, Jeffrey P Raimondi, Jennifer Gogley, Jennifer M Gogley, Jeremiah D Beckwith, Jeremy W Rotton, Jinnie Kokiatkulkij, Joanne M Fukuda, Jocelyn E Massey, Jocelyn E Sparks, Joel D Hustedt, Joel Welch, PhD, Joey V Quitania, John A Gonzalez, John R Myung, Jolanna A Norton, Jose Acruz Gonzalez, Jose R Hernandez, Juan Rjimenez Garcia, Juanita Banuelos, Judy C Nepsa, Julia N Alvarez, Julie A Rorberg, Julie A Stocklin, Junho Pak, Ka L Wong, Kaitlyn R Kornberg, Karen L Kosar, Kari M Johansen, Katherine E Jacobitz, Katherine Szestypalow, Kathleen R Jones, PhD, Kathy Chiu, Kathy Kuo, Kejun Cheng, Kelley, Kellia N Hicks, Kelvin Cheung, Kelvin X Sanders, Kendra A Biddick, Kenneth H Williams, Kent C Faul, Kham Phommachanh, Khoa Nathanv Tran, Kim Lthomas Cruse, Kimberly M Lichter, Lakecha N Lewis, Lance A Finnical, Larry K Austin, Lata C Mathew, PhD, Laura Fontan, MS, Laurimer Kuilan Torres, LCDR Debra Emerson, Leonard H Lavi, Lestine C Webb, Liatte Kreuger, PharmD, Ligia M Sanders, Lilly O Barton, Liming Zhang, Linda F Murphy, Linda Thai, Lindsey M Schwierjohann, Lisa Shin, Lloyd D Payne, Lori B Wikstrom, Lori M Newman, Lori Wikstrom, Louis B Cencetti, Lucila B Nwatu, Luis A Carrion, Marcellinus D Dordunoo, Marcia B Williams, Marcus F Yambot, Marianela Aponte Cruz, Marie F Morin, Marie Falcone, Marie T Falcone, Mark A Tucker, Mark C Saale, Mark E Imsland, Mark R Mcclain, Marybet Lopez Negron, Matthew B Casale, Matthew J Johnson, Maxyne T Lam, Michael A Charles, Michael D Garcia, Michael Shanks, MS, Michael T Cyrus, Michelle A Marsh, Miguel A Martinez Perez, Mihaly S Ligmond, Mohsen Rajabi Abhari, FDA, Mra B Kamberem, Mra Davism, Myra K Casey, Nancy E Boocker, Nancy E Byerly, Nancy Haggard, Naveen B Walker, Nayan J Patel, Nebil A Oumer, Nianna C Burns, Nicholas A Violand, Nicholas L Hunt, Nicholas Obiri, PhD, Nicola M Fenty Stewart, Nicole E Knowlton, Omotunde O Osunsanmi, Paraluman S Leonin, Parul M Patel, Paul L Bellamy, Peter E Baker, Peter S Diak, Phal K Chhun, Philip F Istafanos, DMV, MS, Phillip L Toy, Prasad Peri, PhD, Pratik S Upadhyay, DDC, Rachel C Stanton, Rafael Nevarez Nieves, Rajiv R Srivastava, Ralph H Vocque, Randy L Elsberry, Raymond T Oji, Rebecca K Olin, Rebecca Rodriguez, Richard L Rutherford, Richmond K Yip, Robert C Coleman, Robert D Tollefsen, Robert Darius, Rochelle L Cross, Rocio Guzman Velazquez, Roger F Zabinski, Rona Leblanc, PhD, Ronald L Koller, Ronda Leblanc, Rose Xu, Rowena S Nguyen, Roy R Rinc, Russell J Glapion, Sandra A Hughes, Santiago Gallardo Johnson, Santos E Camara, Sara H Gabel, Sara Jdent Acosta, Sarah A Hassas, Sarah Arden, Sarah M Meng, Scott R Nichols, PhD, Scott T Ballard, Sean R Marcsisin, Sena G Dissmeyer, Sharon K Thoma, PharmD, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sonia R Peterson, Sonya L Karsik, RAC, Sparky L Bartee, Stanley Au, Stefanie L Heckman, Stephanie A Slater, MS, Steven E Porter, Jr, Steven Fong, MS, PhD, Steven M Galvez, Sudipan Karmakar, Sue Lee Chan, Sumit Sen, Sundy V Sedwick, Sunitha K Rajaram, PhD, Susan T Hadman, Susanna E Ford, Susanne M Richardson, MS RAC, Suzanne N Vallez, Suzanne Vallez, Syed N Ali, Tamala P Bogan, Tamala P Magee, Tamika White, Tania Y Hall, Terrance P Nguyen, Terri L Dodds, Thao T Kwan, Thao X Tran, Thomas W Gordon, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tiffani D Wilson, Tonia F Bernard, Tracey L Harris, Tracey T Duong, Truong Xuan Nguyen (Andy), Uduak M Inokon, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vashti E Bocker, Vien Q Le, Vilmary Negron Rodriguez, Virgilio F Pacio, CSO, Virginia Carroll, PhD, Walden H Lee, Wenzheng Wendy Zhang, William J Leonard, Wr Bowman, Yasamin Ameri, Yen Tso Kuo, Yi Wang, PhD, Young M Choi, PhD, Yumi J Hiramine, Yvette Mlacour Davis, Yvins Dezan, Yvonne C Wilkes, Zachary A Bogorad, Zachary L Miller, Zhongren Wu

Taichun Qin, PhD's Documents

Publish Date Document Type Title
August, 2021 FDA 483 ACCU BIO-CHEM LABS - Form 483, 2021-08-31
August, 2016 EIR PYRAMID Laboratories, Inc. - EIR, 2016-08-31
March, 2017 EIR Kindeva Drug Delivery L.P. - EIR, 2017-03-06
February, 2019 EIR Piramal Pharma Limited - EIR, 2019-02-08
November, 2017 FDA 483 Dignity Health - Northridge Hospital Medical Center - Form 483, 2017-11-07
September, 2021 FDA 483 Best Formulations Inc. - Form 483, 2021-09-30
April, 2022 FDA 483 Lynn Oaks Compounding Pharmacy - Form 483, 2022-04-15
December, 2018 FDA 483 Zhejiang Qimei Commodity Co.,Ltd. - Form 483, 2018-12-14
September, 2023 FDA 483 Ajinomoto Althea, Inc. - Form 483, 2023-09-20
May, 2018 FDA 483 Fareva Amboise - Form 483, 2018-05-25
March, 2017 FDA 483 Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical - Form 483, 2017-03-23
September, 2022 FDA 483 MBB Production Mexico S. de R.L. de C.V. - Form 483, 2022-09-29
June, 2021 FDA 483 Advanced Cosmetic Research Laboratories - Form 483, 2021-06-07
September, 2021 EIR Best Formulations Inc. - EIR, 2021-09-30
August, 2019 FDA 483 IOL Chemicals and Pharmaceuticals Ltd. - Form 483, 2019-08-09
July, 2018 FDA 483 SOLARA ACTIVE PHARMA SCIENCES LIMITED - Form 483, 2018-07-27
October, 2018 FDA 483 Hyland's Consumer Health Inc. - Form 483, 2018-10-03
November, 2019 FDA 483 Cipla Ltd. - Form 483, 2019-11-13
August, 2018 FDA 483 Indena India Private Limited - Form 483, 2018-08-03
January, 2020 EIR GMP Laboratories of America Inc - EIR, 2020-01-14
September, 2022 FDA 483 Fersinsa GB, S.A. de C.V. - Form 483, 2022-09-23
April, 2018 FDA 483 Medlife Pharmacy and Compounding - Form 483, 2018-04-18
December, 2018 FDA 483 Changzhou BOHIV Pharmaceutical Technology Co., Ltd - Form 483, 2018-12-07
October, 2019 FDA 483 Natren Inc. - Form 483, 2019-10-08
February, 2020 FDA 483 kdc/one Chatsworth, Inc - Form 483, 2020-02-03
February, 2017 FDA 483 International Medication Systems, Ltd. - Form 483, 2017-02-09
May, 2019 FDA 483 Tianjin Tianyao Pharmaceuticals Co.,Ltd. - Form 483, 2019-05-31
July, 2021 FDA 483 ACRX Specialty Pharmacy Inc - Form 483, 2021-07-23
June, 2018 FDA 483 Parfums Christian Dior - Form 483, 2018-06-08
March, 2017 FDA 483 Kindeva Drug Delivery L.P. - Form 483, 2017-03-06
July, 2018 EIR SOLARA ACTIVE PHARMA SCIENCES LIMITED - EIR, 2018-07-27
April, 2024 FDA 483 Denver Solutions, LLC DBA Leiters Health - Form 483, 2024-04-05
April, 2021 FDA 483 Age Management Institute Santa Barbara - Form 483, 2021-04-12
April, 2023 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2023-04-24
May, 2019 FDA 483 Tianjin Tianyao Pharmaceuticals Co.,Ltd. - Form 483, 2019-05-24
November, 2021 FDA 483 The Belport Company, Inc DBA Gingi-Pak - Form 483, 2021-11-12
March, 2023 FDA 483 Teyro Labs Private Limited` - Form 483, 2023-03-03
January, 2020 FDA 483 GMP Laboratories of America Inc - Form 483, 2020-01-14
July, 2022 FDA 483 DR REDDY'S LABORATORIES LIMITED - Form 483, 2022-07-07
January, 2018 EIR ACTA Laboratories Inc - EIR, 2018-01-19
January, 2018 FDA 483 ACTA Laboratories Inc - Form 483, 2018-01-19
December, 2022 FDA 483 Dalton Chemical Laboratories Inc - Form 483, 2022-12-09
June, 2019 FDA 483 Zhejiang Hisun Pharmaceutical Co., Ltd. - Form 483, 2019-06-07
May, 2019 FDA 483 Rancho Park Compounding Pharmacy - Form 483, 2019-05-07
June, 2018 FDA 483 FAREVA LA VALLEE - Form 483, 2018-06-01
September, 2023 FDA 483 Precision Equine, LLC - Form 483, 2023-09-26
December, 2022 FDA 483 Apotex Pharmachem Inc. - Form 483, 2022-12-16
August, 2019 FDA 483 MADHU INSTRUMENTS PRIVATE LIMITED - Form 483, 2019-08-16
March, 2020 FDA 483 Shine & Pretty (USA), Corp - Form 483, 2020-03-04
January, 2024 FDA 483 Specialty Process Labs - Form 483, 2024-01-26
June, 2024 FDA 483 Fagron Compounding Services - Form 483, 2024-06-28
August, 2024 FDA 483 Empower Clinic Services LLC dba Empower Pharmacy - Form 483, 2024-08-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more